ODDB.org: Open Drug Database

Vitrakvi 20 mg/ml, Lösung zum Einnehmen - 100 ml

Swissmedic Key	67282002	Registration Holder	Bayer (Schweiz) AG
Name	Vitrakvi 20 mg/ml, Lösung zum Einnehmen	Date of registration	28.05.2020
		Introduction of Sequence	28.05.2020
ATC-Classification	Larotrectinib (L01EX12)	Revision date
WHO	WHO-DDD	Valid until	19.02.2029
Index Therapeuticus (BSV)	07.16.10.	Show package size	100 ml
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	1932.71	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	2118.35
Feedback	FB
GTIN	7680672820026	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

larotrectinibum 20 mg ut larotrectinibi sulfas, acidum citricum, maltodextrinum, triethylis citras, aromatica (Erdbeer) cum alcohol benzylicus, propylenglycolum, hydroxypropylbetadexum 174.6 mg, E 211 2 mg, natrii citras dihydricus, sucralosum, aqua purificata, ad solutionem pro 1 ml corresp. natrium max. 4.17 mg.

Packungsbestandteile

Galenic Form

Solution (oral)

Excipiens

Active Agent	Dose
Larotrectinibum	20 mg/ml

BAG: Active Agent	Dose
Larotrectinibum	20 mg

Inactive agents	Dose	additional_information
Citric Acid
Aqua Purificata
Aromatica (Erdbeer) cum Alcohol Benzylicus
E 211	2 mg/ml	conserv.
Hydroxypropylbetadexum	174.6 mg/ml
Maltodextrine
Natrii Citras Dihydricus
Propylenglycol
Sucralosum
Triethylis Citras

Source

Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH